Skip to main content

January 2022

 

 

academics

 

Clinical research courses

Opening for MPharm or MSc at National centre of Cell Sciences, Government of India - Pay upto Rs1 Lakh per month

NCCS is an autonomous institute of Department of Biotechnology, Government of India. It is at the forefront of basic research in diverse area of cell biology. The contributions made by scientists of NCCS have gained worldwide recognition.

Walk in interview for Pharmacist at Tata Memorial Hospital

The Tata Memorial Centre is a Comprehensive Cancer Centre with a mission to achieve the highest standards in patient care, cancer prevention, cancer research and professional development for oncology and allied disciplines. TMC is an autonomous body funded, controlled by the Department of Atomic Energy, Government of India. TMC is affiliated to Homi Bhabha National Institute (HBNI).

Post : Pharmacist

Vacancy for Senior Research Fellow at JIPMER

Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) can trace its origins to the Ecole de Medicine de Pondicherry established by the French Government in 1823. In 1956 foundation for new medical college was laid and in 1964, hospital was inaugurated. JIPMER became an institution of national importance under the Ministry of Health and Family Welfare, Government of India in the year 2008. It is an institution established for teaching, research and patient care in the area of health. JIPMER spreads over 192 acres.

Opportunity for M.Pharm, M.Sc in research project at MPUH

The absence of facilities to treat a given patient in private practice gave rise to the necessity to think of creating an institute which could do justice to such needing population with high degree of care.

Pharma Faculty Jobs at Army Public Schools

There are 136 Army Public Schools (APS) located in various Cantonments and Military Stations across India. These schools are administered and managed by local Army authorities and affiliated to CBSE through Army Welfare Education Society (AWES).

Post for teachers in various categories could be `regular’ or of `fixed term’ nature which shall be informed along with the announcement of vacancies. Appointments which fall in the category of “Regular” would be liable to transfer in organizational interest

Applications are invited for Junior Research Fellow at SGRR University

Applications are invited from Indian Nationals for the post of Junior Research Fellow in Department of Pharmacognosy, SPS, SGRR University, Dehradun, Uttarakhand for the Uttarakhand State Council for Science & Technology (UCOST) Research Fund project entitled "Phytopharmaceuticals analysis based identification and comparison of tissue-cultured Zonthoxylum armatum DC. (Timur) species with their wild correspondences and development of smart recommender system for cultivation in Uttarakhand Himalayan region" under Principal Investigator Dr.

Job for M.Pharm as Process development scientist at Dr. Reddys Laboratories

Dr. Reddys Laboratories is an emerging global pharmaceutical company with proven research capabilities. The company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia.

Post : Process development scientist

Ciclopirox olamine & Ciclopirox : Broad Spectrum Anti-fungal

Vinay Kumar SinghAbout Author
Vinay Kumar Singh.  
Head-Formulation
Kumar Organic Products Research Centre Pvt. Ltd.,
Bengaluru
Email : formulation_krc@kopresearchcentre.net

Marker Therapeutics Receives FDA Orphan Drug Designation for its Multi-Antigen Targeted T Cell Therapy for Pancreatic Cancer

Marker Therapeutics, Inc a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that the United States Food and Drug Administration (FDA) Office of Orphan Products Development has granted Orphan Drug designation to MT-601, a multi-tumor-associated antigen (MultiTAA)-specific T cell product optimized for the treatment of patients with pancreatic cancer.

Idorsia receives Japanese PMDA approval of PIVLAZ (clazosentan sodium)150 mg

Idorsia Ltd and Idorsia Pharmaceuticals Japan today announce that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has approved PIVLAZ™ (clazosentan sodium) 150 mg, a selective endothelin A (ETA) receptor antagonist, for the prevention of cerebral vasospasm, vasospasm-related cerebral infarction and cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage (aSAH). The PMDA approval of PIVLAZ is based on a dedicated Japanese Phase 3 program.